HIV biological phenotype: prognosis marker for transmission, disease progression and therapy.
Fenyö
E M
EM
Microbiology and Tumorbiology Center, Karolinska Institute, Stockholm, Sweden.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000821:virology; D018450:Disease Progression; D018562:Disease Transmission, Infectious; D004352:Drug Resistance, Microbial; D015658:HIV Infections / Q000188:drug therapy* / Q000635:transmission / Q000821:virology*; D015497:HIV-1 / Q000145:classification / Q000472:pathogenicity*; D006801:Humans; D010641:Phenotype; D011379:Prognosis; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D015215:Zidovudine